Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |